Indian stocks: Visit www.stage2stocks.com →

Cryo-Cell International, Inc.

Stage 2 · Advancing · week 9

As of Oct 22, 2026, Cryo-Cell International is in Stage 2, the uptrend phase, now in week 9 (since Aug 21, 2026). It closed at $4.49, 5.5% below its 52-week high and above its 200-day average, which is rising.

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. More about the company

$4.49
-4.06% today
$36.2M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 17 in Medical Care Facilities · #1 of 272 in Health Care

Is CCEL early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 16w
S4 17w
S4 35w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 4w → S3 10w → S4 2w → S3 1w → S2 11w → S3 1w → S4 3w → S1 1w → S2 16w → S3 9w → S4 7w → S1 3w → S2 9w → S3 9w → S4 17w → S1 1w → S4 35w → S1 11w → S4 5w → S1 1w → S2 9w current
Total tracked: 165 weeks across 21 stage runs.

CCEL among Medical Care Facilities25th of 49 by relative strength

All 49 →
Stocks in Medical Care Facilities ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AGLStage 3 · wk 898+6.8%
2PACSStage 3 · wk 498+15.7%
3LFSTStage 2 · wk 2497+4.0%
4AMNStage 2 · wk 2596+38.1%
5NHCStage 2 · wk 5995+8.4%
6CONStage 2 · wk 2294+14.9%
7INNVStage 3 · wk 593+5.8%
8MDStage 2 · wk 2692+14.3%
…25CCELStage 2 · wk 957+12.5%
vs 52W High
-5.5%
$2.89 lo$4.75 hi
5.5% below 52W high, pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 9
1w13w26w
Week 9, early Stage 2
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
23.5%
200 DMA: $3.63 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
0.23x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
Short-term trend rising gently
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+12.5%
3M
+29.8%
6M
+14.8%
YTD
+30.9%
1Y
+3.2%
Scan Membership
Breakout Watch
Latest: 2024-12-03
9 appearances in last 60 days. First seen: 2019-07-09.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 9 · Vol 0.23x
2026-10-21S2
Wk 9 · Vol 0.40x
2026-10-20S2
Wk 9 · Vol 0.24x
2026-10-19S2
Wk 9 · Vol 0.28x
2026-10-16S2
Wk 8 · Vol 0.36x
2026-10-15S2
Wk 8 · Vol 0.58x
2026-10-14S2
Wk 8 · Vol 0.33x
2026-10-13S2
Wk 8 · Vol 0.53x
2026-10-12S2
Wk 8 · Vol 1.57x
2026-10-09S2
Wk 7 · Vol 0.20x
2026-10-08S2
Wk 7 · Vol 1.84x
2026-10-07S2
Wk 7 · Vol 0.15x
Moving averages & range
50 DMA
$4.18
200 DMA
$3.63
52W High
$4.75
52W Low
$2.89
5D Low
$4.42
Resistance levels (recent highs)
20d High
$4.75
60d High
$4.75
120d High
$4.75
250d High
$4.75
Next resistance
+5.8%
to 20d High
Earnings Growth (YoY)
+75.1%
Revenue 0.0%
Dividend Yield
0.00%
P/B -2.2

Cryo-Cell International: quick answers

What stage is Cryo-Cell International in?

As of Oct 22, 2026, Cryo-Cell International (CCEL) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 21, 2026 and is in week 9. What the four stages mean

Is Cryo-Cell International in an uptrend?

Yes. Cryo-Cell International is in a Stage 2 uptrend. It trades 23.5% above its 200-day average, which is rising.

How far is Cryo-Cell International from its 52-week high?

Cryo-Cell International closed at $4.49 on Oct 22, 2026, 5.5% below its 52-week high of $4.75. Its 52-week low is $2.89.

How has Cryo-Cell International performed over the past year?

As of Oct 22, 2026, Cryo-Cell International is up 3.2% over the past year and up 30.9% so far in 2026.

Which sector and industry is Cryo-Cell International in?

Cryo-Cell International is in the Medical Care Facilities industry, part of the Health Care sector.

About this companyHealth Care· Medical Care Facilities

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.